Results 181 to 190 of about 15,512 (295)

Resistant Peanut Genotype Reprograms Rhizosphere Metabolism to Enhance Bacterial Wilt Suppression

Advanced Science, EarlyView.
The resistant peanut genotype selectively recruits beneficial bacteria, which coincides with the activation of salicylic acid (SA)‐dependent systemic acquired resistance (SAR) against Ralstonia solanacearum. Keystone rhizosphere metabolites are positively correlated with both beneficial microbiome assembly and SAR gene expression.
Rui Ren, Xiaogang Li, Hao Li, Zenghui Cao, Mengtian Hou, Chunlei Zhao, Nan Lou, Sasa Hu, Yanzhe Li, Qian Ma, Yaoyao Li, Yi Fan, Kunkun Zhao, Kai Zhao, Ding Qiu, Fangping Gong, Zhongfeng Li, Haitao Liu, Xingli Ma, Xingxiang Wang, Dongmei Yin   +20 more
wiley   +1 more source

Economic Evaluation of Antibacterials in the Treatment of Acute Sinusitis

Objective: The objective of this study was to compare costs, efficacy and cost efficacy of alternate oral antibacterial regimens for the ambulatory treatment of acute sinusitis. A public third-party perspective was adopted. Design: The analysis was based
Murray Ducharme, Jean Lachaine, Claudine Laurier   +2 more
core  

Visual assessment of antimicrobial medicine packaging and labeling quality in pharmacies of Ho Municipality, Ghana. [PDF]

PLoS One
Orman E, Ankah BD, Oteng D, Mccarthur D, Aku TA, Hutton-Nyameaye AA, Jato J, Odoi H, Somuah SO, Collison-Cofie INA, Jani YH, Dodoo C.   +11 more
europepmc   +1 more source

De Novo Design of Membrane‐Targeting Antimicrobial Peptides Against Gram‐Negative Bacteria Using a Generative Artificial Intelligence Framework

Advanced Science, EarlyView.
Antimicrobial resistance caused by Gram‐negative bacteria remains difficult to overcome due to the protective outer membrane. To address this challenge, a multi‐condition constrained generative AI framework, GenMTAMP is proposed for de novo membrane‐targeting antimicrobial peptide design by integrating physicochemical and spatial structure descriptors.
Jingxiao Yu, Da‐Wen Sun, QingYi Wei, Yibing Zhang, Jidong Tang, Hongbin Pu   +5 more
wiley   +1 more source

Antimicrobial resistance in bacteria

Open Medicine, 2009
Bockstael Katrijn, Aerschot Arthur
doaj   +1 more source

Microblasting Wound Dressings Mechanically Disrupt Polymicrobial Biofilms to Enhance Healing in Treatment‐Resistant Wounds

Advanced Science, EarlyView.
Treatment‐resistant wounds caused by polymicrobial biofilms are refractory to conventional therapies due to the dense extracellular matrices. We developed μBLAST, a microblasting wound dressing that combines MnO2‐doped biosilica and a H2O2‐releasing mesh to generate localized oxygen microbubbles that mechanically disrupt biofilms.
Yujin Ahn, Joo Hun Lee, Christian Hurd, Jiye Lee, Junggeon Park, Adam A. Markowicz, Zheyuan Zhang, Joanne Hwang, Guillermo L. Monroy, Simon A. Rogers, Woonggyu Jung, Stephen A. Boppart, Hyunjoon Kong   +12 more
wiley   +1 more source

Benchmarking Pre-National Action Plan Systemic Antimicrobial Consumption in Tanzania, 1998-2005: A Historical Longitudinal Defined Daily Dose Analysis. [PDF]

Cureus
Sangeda RZ, Kadinde AW, Khea A, Fimbo AM.   +3 more
europepmc   +1 more source

Antibacterial Chemotherapy

International Journal of Clinical Practice, 1969
openaire   +2 more sources

Biodegradable Zn‐Based Implants: Progress, Challenges, and Pathways toward Clinical Translation

Advanced Science, EarlyView.
Exploring biodegradable Zn‐based implants offers a promising pathway to next‐generation biomedical devices with balanced degradation and biocompatibility. A comprehensive overview of biodegradable Zn‐based implants, covering their biological significance, material design principles, and advanced engineering strategies is provided.
Panfeng Zhao, Zhengquan Wang, Hui Yang, Xiyuan Zhang, Hanyuan Liu, Xiaotong Lu, Xiaocheng Li, Yanyan Liu, Xi Zhao, Wenhao Zhou, Yufeng Zheng   +10 more
wiley   +1 more source

TREATment of Lower Respiratory Tract Infection in Selected Hospitals in Southern Sri Lanka (TREAT-SL): study protocol for a stepped-wedge, cluster-randomized clinical trial. [PDF]

Trials
De Zoysa PDWD, Weerasinghe SA, Gamage J, Iglesias-Ussel MD, Olague S, Obale A, Gallis JA, Palangasinghe D, Senadheera B, Vasana S, Nix C, Bodinayake CK, Nagahawatte ADS, Wijayaratne WMDGB, Kurukulasooriya MRP, Premamali M, Dilshan UHBY, Ngocho J, Østbye T, Laber EB, Watt MH, Myers E, Woods CW, Naggie S, Kenny A, Chakraborty H, Tillekeratne LG.   +26 more
europepmc   +1 more source